Non-randomized Experimental Study Evaluating the Impact of Implantation of a New Organization in the Adult Sector Intended to Improve the Transition of Young People With Endocrine or Metabolic Diseases
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Pediatric Patient Transfer to Adult Service:Transition Program
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Enrollment
- 202
- Locations
- 1
- Primary Endpoint
- Rate of patients lost to follow-up at 24 months post transfert
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
"Transend" is a program designed to promote the transition of young patients with endocrine or metabolic diseases when they arrive in the adult sector at La Pitié-Salpétrière hospital. The main objective of the study is to compare the rate of patients lost to follow-up at 24 months after the transfer of pediatrics between the Transend group and the (historical) control group.
Detailed Description
Adolescence and early adulthood represent important periods for young people suffering from chronic diseases. Several observational studies show needs not covered by care services at this period and significant lost to follow-up rates. "Transend" is a program designed to promote the transition of young patients with endocrine or metabolic diseases when they arrive in the adult sector at La Pitié-Salpétrière hospital (Paris, France). Since September 1, 2016, approximately 500 patients benefited from it.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patient aged 18 to 32
- •Patient with endocrine or metabolic disease
- •Patient who had a follow-up in a pediatric department for his endocrine or metabolic disease
- •Patient transferred to the adult sector in the endocrinology, metabolism or nutrition department of Pitié-Salpêtrière
- •Patient who had a first post-transfer consultation between January 1, 2015 and September 1, 2017
- •Patient with a social security protection
Exclusion Criteria
- •Patient who transferred to another adult service before being followed at Pitié-Salpêtrière
- •Patient who has expressed his opposition to participate in this research
Outcomes
Primary Outcomes
Rate of patients lost to follow-up at 24 months post transfert
Time Frame: 24 months post transfert
Defined by pathology as patients who have not been seen in a medical consultation since a time superior of the recommendation for his state of Heath at 24 months post-transfer and for whom no elements confirm a next consultation in the center nor a follow-up in another center
Secondary Outcomes
- Number of consultations not honored by the patient(24 to 36 months post transfert)
- Assess Transend's efficiency(24 to 36 months post transfret)
- Avoided care consumption and associated costs(24 to 36 months post transfret)
- Time to first consultation in adult medicine(24 to 36 months post transfert)
- Patient satisfaction(24 to 36 months post transfet)
- Compare the experience of the transition betmeen the two Groups(24 to 36 months post transfret)
- Relationship of trust between caregiver and patient(24 to 36 months post transfert)